HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

6th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 20-22, 2025 | Orlando, Florida, USA

GAB 2023

Affordances vs task management: Evoking agency and addiction

Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2023 - Denis Larrivee
University of Navarra Medical School, Spain
Title : Affordances vs task management: Evoking agency and addiction

Abstract:

Neural mechanisms for self regulation feature prominently in studies of addiction, which is characterized by the inability to resist compulsive behavior. Such neural mechanisms involve not just top down processes needed in the execution of decision making events, but also the neural representation of the self/agent, generally regarded as the source of decision making capacity. Impairments of this latter representation can be expected to weaken the ability to enlist capacities for self regulation. How the agent may be represented, nevertheless, has remained an enigma. General models of brain organization increasingly invoke stable networks, termed resting state networks (RSNs), which organize brain activity for the support of diverse brain functions. Much evidence now points toward their involvement in a spectrum of neurological dysfunctions and in psychiatric diseases, such as major depressive disorder autism, attention deficit/hyperactivity and schizophrenia. Hence, they are likely to be impaired  in addiction abnormalities as well. Current work indicates that bodily representation is a key aspect underpinning the source of top down agent mediated events, particularly those associated with motor actions and RSNs associated with this representation could therefore be impaired in addiction. Significantly, diseases of agency like schizophrenia are known to impair bodily representation and to also affect goal directed neural correlates like those of the mirror system. This talk will explore the relationship between the broader representation needed to underpin the agent and resting network brain operation in such cognitive diseases to gain insight into how agent representation may be impaired in addiction.

Biography:

Dr. Denis Larrivee is a visiting scholar at the Mind and Brain Institute, University of Navarra Medical School and Loyola University, Chicago. He has held professorships at the Weill Cornell University Medical College, NYC, and Purdue University, Indiana. A former fellow at Yale University's Medical School, Dr. Larrivee received the Association for Research in Vision and Ophthalmology's first place award for studies on photoreceptor degenerative and developmental mechanisms. He maintains an active interest in medical imaging technology and recently published an edited volume on current advances in magnetic resonance imaging. He is the editor of six additional texts on clinical neuroscience and neurotechnology and is an editorial board member of the Annals of Neurology and Neurological Sciences (USA) and EC Neurology (UK). Dr Larrivee is the lead author of more than one hundred papers and book chapters in such varied journals/venues as IEEE Xplore, the Journal of Neuroscience, Frontiers Human Neuroscience, and the Journal of Religion and Mental Health, including a recent article in the Journal of Responsible Innovation on the integration of ethics in medical neurotechnology design. In 2018, he was a finalist for the international Joseph Ratzinger Expanded Reason award sponsored by the Francis Vittorio University of Madrid. He is currently a member of the USA based IEEE BRAIN Task Force on value based design of medical neurotechnologies.

Watsapp